Dr. Maller is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1310 Road
Wynnewood
Wynnewood, PA 19096Phone+1 610-246-3571
Education & Training
Children's Hospital of PhiladelphiaFellowship, Pediatric Gastroenterology, 1984 - 1987
Boston Children’s Hospital/Boston Medical CenterFellowship, Adolescent Medicine, 1983 - 1984- Boston Children’s Hospital/Boston Medical CenterResidency, Pediatrics, 1980 - 1983
Harvard Medical SchoolClass of 1980
Certifications & Licensure
PA State Medical License 1984 - 2024- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Gastroenterology
Publications & Presentations
PubMed
- 18 citationsExtraintestinal manifestations at baseline, and the effect of tofacitinib, in patients with moderate to severe ulcerative colitis.David T. Rubin, Walter Reinisch, Thomas Greuter, Paulo Gustavo Kotze, Marcia Pinheiro
Therapeutic Advances in Gastroenterology. 2021-05-16 - 8 citationsThe Impact of Raising the Bar for Clinical Trials in Ulcerative Colitis.Bruce E. Sands, Adam S. Cheifetz, Chudy I. Nduaka, Daniel Quirk, Wenjin Wang
Journal of Crohn's & Colitis. 2019-09-19 - 26 citationsLong-term safety and tolerability of oral tofacitinib in patients with Crohn’s disease: results from a phase 2, open-label, 48-week extension studyJulián Panés, Geert R. D'Haens, Peter D.R. Higgins, Linda Mele, Michele Moscariello
Alimentary Pharmacology & Therapeutics. 2019-02-01
Press Mentions
Consensus: Guidelines: Best Practices for Detection, Assessment and Management of Suspected Acute Drug-Induced Liver Injury During Clinical Trials in Patients with Nonalcoholic SteatohepatitisFebruary 13th, 2020
Grant Support
- Lamivudine In Pediatric Subjects With Hepatitis BNational Center For Research Resources2000–2002
- Intron A PLUS Ribavirin In Pediatric Hepatitis CNational Center For Research Resources2000–2002
- Ursodeoxychloric Acid In Cystic Fibrosis Associated Liver DiseaseNational Center For Research Resources1995–1997
- Dose Response Ursodeoxycholic Acid In Cystic Fibrosis-Associated Liver DiseaseNational Center For Research Resources1994–1995
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
